
Diagnostics Insights


Optimising Heart Failure GDMT with the Rapid Titration (RaT) Pathway comprising several hospitals in Northland

Reducing Mortality and Readmission with HF Multidisciplinary Model of Care

Culturally Sensitive Diabetes Care

HbA1c discrepancies: How can ambulatory glucose profile (AGP) help?

Menopause and Diabetes

Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP

Value of biomarker in HFpEF Diagnosis

Sex-specific Differences in Heart Failure

Management of CVD in Patients with Diabetes

Heart Failure Care Beyond City Limits: Insights from a Cardiologist

Implementation of STRONG-HF protocol in heart failure management: an Australian perspective

When every minute counts: A deep dive into IJN Malaysia’s quest for rapid triage for chest pain patients in the ED

Quantum leap in reducing rehospitalization in HF by 70-80% – How and where?

Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment

Perioperative myocardial injury (PMI) management: Challenges and feasibility of active screening in non-cardiac surgeries

Heart Failure Management in India – Overcoming Present Challenges

Rational use of troponin and optimal management of cardiovascular diseases

The evidence for 0/1-hour algorithm for Asia? DROP-Asian ACS Study

Process Optimization for Emergency hs-TnT Detection

Clinical Application Value of NT-proBNP in Chronic Kidney Diseases Patients with Cardiovascular Diseases

High Sensitivity Troponin vs Conventional Troponin: An Expert View


The rationale for the use of hs-cTn in the optimal management of ACS


Rapid algorithms for hs-cTn in ED: Boon or Bane?



STROKESTOP II Study: Precision risk screening for atrial fibrillation in elderly



Atrial Fibrillation in Elderly: Screening tools and role of NT-proBNP


Advantages of early NT-proBNP testing in patients suspected with heart failure


NT-proBNP: Increasing Clinical Confidence in Heart Failure Management


What is the Peptide for Life initiative?


Heart Failure in Asia – Present Challenges and Future Strategies


Perioperative Myocardial Infarction in Non-Cardiac Surgery – Why Measuring Troponin is Important?


Heart Failure Prevention in T2DM – Essence of JCS/JDS joint consensus








CANVAS study: NT-proBNP and CVD risk reduction


What should we take note of when using hs-TnT for CKD patient?


Clinical Relevance of hs-Tn age specific cut-offs


Clinical Relevance of hs-TnT gender specific cut-offs


Recommended Steps to Implement 0h/1h Algorithm in Asia


Benefits of 0h/1h Algorithm in a Thai Institution


Benefits of 0h/1h Algorithm to Patients in Asia








How will NT-proBNP testing evolve in the future?



Is NT-proBNP validated for different population groups?








Reference ranges for NT-proBNP & hs-TnT in Asian populations


Benefits of the 0h/1h algorithm in a Japanese institution


Patient Case Studies Using 0h/1h Algorithm








BNP vs NT-proBNP: An Expert View








Impact of ARNi Therapy on Natriuretic Peptide Use



How to Use NT-proBNP for Prognosis and Monitoring?



What Should Hospitals Consider when Implementing Rapid Algorithm?


TRAPID-AMI sub-study: Use of very low concentration of hs-TnT to rule out AMI using a single blood test



Benefits of hs-Tn 0h/1h Algorithm in ED & Hospital


TRAPID-AMI Study: hs-TnT for Rapid Rule In/ Out of AMI


Benefits of hs-Tn 0h/1h Algorithm to Chest Pain Patients








How NT-proBNP Made a Difference: Dr Januzzi’s Patient Story


Impact of hs-Tn on Further Cardiac Testing in Suspected AMI Patients


Switching from Conventional to High-Sensitivity Troponin


How hs-TnT Made a Difference – Dr Twerenbold’s Story



How NT-proBNP Made a Difference: Dr Richards’ Patient Story








Natriuretic Peptides in the Latest ESC & AHA HF Guidelines


